Plasma concentrations of high-dose olanzapine in a double-blind crossover study.

Kelly, Deanna L; Richardson, Charles M; Yu, Yang; Conley, Robert R

Kelly, Deanna L; Richardson, Charles M; Yu, Yang; Conley, Robert R.

Affiliation

Kelly DL; Maryland Psychiatric Research Center, University of Maryland, Baltimore, Maryland 21228, USA. dkelly@mprc.maryland.edu

Hum Psychopharmacol ; 21(6): 393-8, 2006 Aug.

Article in En | MEDLINE | ID: mdl-16850522

Subject(s)

Antipsychotic Agents/administration & dosage; Antipsychotic Agents/blood; Schizophrenia/blood; Adult; Antipsychotic Agents/adverse effects; Benzodiazepines/administration & dosage; Benzodiazepines/adverse effects; Benzodiazepines/blood; Clozapine/administration & dosage; Clozapine/blood; Constipation/chemically induced; Cross-Over Studies; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Olanzapine; Risk Factors; Schizophrenia/drug therapy; Severity of Illness Index; Sex Characteristics; Sex Factors; Smoking/adverse effects; Time Factors; Treatment Outcome; Vision Disorders/chemically induced; Xerostomia/chemically induced

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Schizophrenia / Antipsychotic Agents Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male Language: En Journal: Hum Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2006 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links